Vaccines for tick-borne diseases and cost-effectiveness of vaccination: a public health challenge to reduce the diseases’ burden

Lyme borreliosis: reviewing potential vaccines, clinical aspects and health economics

(2015) Renata Šmit et al.   Expert Review of Vaccines

Tick borne encephalitis (TBE)-vaccination coverage and analysis of variables associated with vaccination, Sweden

(2015) Helena Hervius Askling et al.   VACCINE

Review of tick-borne encephalitis and vaccines: clinical and economical aspects

(2014) Renata Šmit et al.   Expert Review of Vaccines

Disability-Adjusted Life Years (Dalys) as a Composite Measure to Express the Burden of Tick-Borne Encephalitis (Tbe) in Slovenia

(2014) R. ŠMIT et al.   VALUE IN HEALTH

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

(2013) Nina Wressnigg et al.   LANCET INFECTIOUS DISEASES

Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults

(2012) Renata Šmit   VACCINE

Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe

(2010) G. Stanek et al.   CLINICAL MICROBIOLOGY AND INFECTION

Lyme borreliosis vaccination: the facts, the challenge, the future

(2010) T.J. Schuijt et al.   TRENDS IN PARASITOLOGY